Genetic information can help with selected prescribing decisions, but it is one part of medication safety and cannot identify a perfect drug for everyone.
Read repeat-expansion reports: test scope, detection versus sizing, DMPK and FMR1 examples, and what a negative exome or genome result leaves unresolved.
Understand the chromosome changes behind Down syndrome, what testing can establish, why individual outcomes vary and how established care differs from research.